Takeda Pinpoints Four Infectious Diseases Under Vaccines Strategy

 
• By Lucie Ellis-Taitt

Medical head of Takeda's vaccines business unit, Gary Dubin, talks to Scrip about the company's development strategy for important infectious diseases and the difficulties of designing clinical trials for vaccines against some of the world's most unpredictable viruses.

ChildInjection_1200x675
Takeda's vaccines unit is focused on protective agents against Zika, dengue fever, polio and norovirus • Source: Shutterstock

More from Anti-infective

More from Therapy Areas